血管内皮生长因子B(VEGFB)活性蛋白

Active Vascular Endothelial Growth Factor B (VEGFB)

VEGF-B; VEGFL; VRF; VEGF-Related Factor

  • 血管内皮生长因子B(VEGFB)活性蛋白 产品包装(模拟)
  • 血管内皮生长因子B(VEGFB)活性蛋白 产品包装(模拟)
  • Certificate 通过ISO 9001、ISO 13485质量体系认证

活性实验

用法

Reconstitute in 20mM Tris, 150mM NaCl (PH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

储存

避免反复冻融。2-8°C不超过一个月,-80°C不超过12个月。

稳定性

热稳定性以损失率显示。损失率是由加速降解试验决定,具体方法如下:在37°C孵育48小时,没有显著的降解或者沉淀产生。保质期内,在适当的条件下存储,损失率低于5%。

相关产品

编号 适用物种:Homo sapiens (Human,人) 应用(仅供研究使用,不用于临床诊断!)
RPA144Hu01 血管内皮生长因子B(VEGFB)重组蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
APA144Hu01 血管内皮生长因子B(VEGFB)活性蛋白 Cell culture; Activity Assays.
PAA144Hu01 血管内皮生长因子B(VEGFB)多克隆抗体 WB; IHC; ICC; IP.
LAA144Hu71 血管内皮生长因子B(VEGFB)多克隆抗体(生物素标记) WB; IHC; ICC.
LAA144Hu81 血管内皮生长因子B(VEGFB)多克隆抗体(异硫氰酸荧光素标记) WB; IHC; ICC; IF.
MAA144Hu22 血管内皮生长因子B(VEGFB)单克隆抗体 WB; IHC; ICC; IP.
LAA144Hu82 血管内皮生长因子B(VEGFB)单克隆抗体(异硫氰酸荧光素标记) WB; IHC; ICC; IF.
LAA144Hu72 血管内皮生长因子B(VEGFB)单克隆抗体(生物素标记) WB; IHC; ICC.
SEA144Hu 血管内皮生长因子B(VEGFB)检测试剂盒(酶联免疫吸附试验法) Enzyme-linked immunosorbent assay for Antigen Detection.
LMA144Hu 血管内皮生长因子B(VEGFB)等多因子检测试剂盒(流式荧光发光法) FLIA Assay for Antigen Detection.

参考文献

杂志 参考文献
International Journal of Cardiology Reduced microvascular density in non-ischemic myocardium of patients with recent non-ST-segment-elevation myocardial infarction. [PubMed: 22459379]
Applied Sciences-Basel Assessment of annexin A5 and annexin A2 levels as biomarkers for pre-eclampsia: A pilot study [pubmed:29099033]
Journal of Endocrinological Investigation Plasma vascular endothelial growth factor B levels are increased in patients with newly diagnosed type 2 diabetes mellitus and associated with the first phase of glucose-stimulated insulin secretion function of β-cell [10.1007/s40618-017-0677-z]
EXCLI Journal Plasma vascular endothelial growth factor B is elevated in non-alcoholic fatty liver disease patients and associated with blood pressure and renal dysfunction []
Cancer Chemother Pharmacol Phase 1 study of safety, pharmacokinetics, and pharmacodynamics of tivantinib in combination with bevacizumab in adult patients with advanced solid tumors [34164713]
留言咨询